The impact of long-read sequencing on human population-scale genomics
Genome Research · 2025
DOI: 10.1101/gr.280120.124 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genome Research, 2025. Verfasst von Tobias Rausch und 2 weiteren Autor:innen. Beteiligte Einrichtung: European Molecular Biology Laboratory (EMBL), Genome Biology Unit, 69117 Heidelberg, Germany; tobias.rausch@embl.de tobias.marschall@hhu.de jan.korbe…. Hauptthemen laut MEDLINE: Genomics, Genome, Human, High-Throughput Nucleotide Sequencing, Sequence Analysis, DNA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Long-read sequencing technologies, particularly those from Pacific Biosciences and Oxford Nanopore Technologies, are revolutionizing genome research by providing high-resolution insights into complex and repetitive regions of the human genome that were previously inaccessible. These advances have been particularly enabling for the comprehensive detection of genomic structural variants (SVs), which is critical for linking genotype to phenotype in population-scale and rare disease studies, as well as in cancer. Recent developments in sequencing throughput and computational methods, such as pangenome graphs and haplotype-resolved assemblies, are paving the way for the future inclusion of long-read sequencing in clinical cohort studies and disease diagnostics. DNA methylation signals directly obtained from long reads enhance the utility of single-molecule long-read sequencing technologies by enabling molecular phenotypes to be interpreted, and by allowing the identification of the parent of origin of de novo mutations. Despite this recent progress, challenges remain in scaling long-read technologies to large populations due to cost, computational complexity, and the lack of tools to facilitate the efficient interpretation of SVs in graphs. This perspective provides a succinct review on the current state of long-read sequencing in genomics by highlighting its transformative potential and key hurdles, and emphasizing future opportunities for advancing the understanding of human genetic diversity and diseases through population-scale long-read analysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- European Molecular Biology Laboratory (EMBL), Genome Biology Unit, 69117 Heidelberg, Germany; tobias.rausch@embl.de tobias.marschall@hhu.de jan.korbel@embl.org.
- Institute for Medical Biometry and Bioinformatics, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University, 40225 Düsseldorf, Germany; tobias.rausch@embl.de tobias.marschall@hhu.de jan.korbel@embl.…
- Center for Digital Medicine, Heinrich Heine University, 40225 Düsseldorf, Germany.
ORCID-Profile: Tobias Rausch, Tobias Marschall, Jan O Korbel
Zitieren
APA
Rausch, T., Marschall, T., & Korbel, J. O. (2025). The impact of long-read sequencing on human population-scale genomics. Genome Research. https://doi.org/10.1101/gr.280120.124
Vancouver
Rausch T, Marschall T, Korbel JO. The impact of long-read sequencing on human population-scale genomics. Genome Research. 2025. doi:10.1101/gr.280120.124
BibTeX
@article{Rausch2025,
author = {Rausch, Tobias and Marschall, Tobias and Korbel, Jan O},
title = {The impact of long-read sequencing on human population-scale genomics},
journal = {Genome Research},
year = {2025},
doi = {10.1101/gr.280120.124}
}
EUVIMED